Colors: Green Color

Group 42 (G42), a leading AI and Cloud Computing company based in the United Arab Emirates, and Oxford Nanopore Technologies, an advanced sequencing technology company based in the United Kingdom, announced today they have developed an unprecedented population-scale technology that rapidly and accurately detects SARS-CoV-2, the virus that causes COVID-19. The end-to-end solution will be officially launched within weeks.

Dr. Amer Ahmad Sharif, Chairman of the Covid-19 Command and Control Centre & Vice Chancellor of the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and Dr. Muna Tahlak, CEO-Latifa Hospital formally inaugurated the 50 bed critical care Aster Hospital in Muhaisnah, Dubai, UAE in the presence of Ms. Alisha Moopen- Deputy Managing Director at Aster DM Healthcare, Mr. Shamsudheen AP- Director at Aster DM Healthcare & Chairman of Regency Group, Dr. Sherbaz Bichu- CEO of Aster Hospitals UAE, other dignitaries and staff.

Narcolepsy is a chronic neurological disorder affecting the part of your brain that regulates sleep. As a result, the patient experience excessive daytime sleepiness and a sudden loss of muscle control (called cataplexy) causing you to fall asleep during normal daytime activities such as working or studying. These episodes are often triggered by strong emotions. Narcolepsy is more common than you probably realize affecting about 1 in 2,000 people—and while there is not yet a cure, there are plenty of ways you can reduce the symptoms.

Tygrus LLC announced today that tests conducted by a Center for Disease Control and Prevention (CDC) authorized Bio Safety Level 3 laboratory on its new ingredient, Tydracide, showed that the formulation eliminated the SARS-CoV-2 virus in 1 minute at greater than 5-Log (99.999%) reduction. The tests were conducted on the SARS-CoV-2 virus, the actual virus that causes COVID-19 and not a surrogate virus.